300765SZSE

Announcement of Resolutions from the First Extraordinary Shareholders' Meeting of 2026

CSPC Innovation Pharmaceutical Co., Ltd.·

✨ AI Summary

The first extraordinary shareholders' meeting of 2026 was held on February 24, 2026, with 381 shareholders present, representing 116,520,295 shares (8.3671% of total voting shares). The meeting approved a proposal for a strategic cooperation and authorization agreement with AstraZeneca, with 99.6844% voting in favor. Legal opinions confirmed the meeting's compliance with relevant laws and regulations.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai
  1. Stock Code: 300765
    Stock Abbreviation: Xinnowei
    Announcement Number: 2026-011

Shiyao Innovation Pharmaceutical Co., Ltd.
Announcement of Resolutions from the First Extraordinary Shareholders' Meeting of 2026

The company and all members of the board of directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.

Special Reminder:

  1. There were no rejected proposals at this shareholders' meeting.
  2. This shareholders' meeting does not involve changes to resolutions previously approved by past shareholders' meetings.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Sign in to read moreSee Pro pricing